Dublin, July 21, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/bj2jw7/global) has announced the addition of the "Global Inflammatory Bowel Disease Market 2015-2019" report to their offering.
This report covers the present scenario and the growth prospects of the Global Inflammatory Bowel Disease market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of inflammatory bowel disease. The market includes data from the sales of various drusg which are used for the treatment of Crohn's Disease and Ulcerative Colitis.
The dominance of the market by biologics used to treat patients suffering from the disease is one of the emerging trends. Biologics are expected to become a preferred treatment option for the medical fraternity, patients, and the families of patients during the forecast period. This leads to a rise in the number of treatment-seeking patients, which increases the overall consumption of medicines.
According to the report, the high prevalence of inflammatory bowel disease among the population resulting in a rise in the number of treatment-seeking patients has led to increased consumption of medications, thereby having a positive impact on the market share of the vendors.
Further, the report states the high cost of drugs used to treat patients suffering from inflammatory bowel disease is one of the major challenges hindering the growth of the market.
On the basis of the functioning of the drugs used for treatment, the Global Inflammatory Bowel Disease market is categorized into three segments.
- 5-ASA
- Antibiotics
- Immunomodulators
On the basis of the type of molecule used for treatment, the Global Inflammatory Bowel Disease market is categorized into two segments.
- Biologics
- Small Molecules
On the basis of route of administration adopted for the treatment, the Global Inflammatory Bowel Disease market is categorized into two segments.
- Oral
- Parenteral
On the basis of the form of drug used to treat the disease, the Global Inflammatory Bowel Disease market is categorized into two segments.
- Solid
- Liquid
Key Vendors
- Abbvie
- Biogen Idec
- Janssen Pharmaceuticals
- Merck & Company
- Shire
- UCB
Other Prominent Vendors
- Amgen
- Akebia Therapeutics
- Boehringer Ingelheim
- Celltrion
- ChemoCentryx
- Ferring Pharmaceuticals
- Galapagos
- Genentech
- Merck
- Mitsubishi Tanabe
- Novartis
- Novo Nordisk
- Pfizer
- Salix Pharmaceuticals
For more information visit http://www.researchandmarkets.com/research/bj2jw7/global